In their quest to fight and win over diseases, scientists are relentlessly pursuing new treatments to cure or prevent diseases and help prolong or improve the lives of people affected by various illnesses.
The newly discovered treatments cannot be made available for public use unless they are tested in clinical trials. The Food and Drug Administration (FDA) requires clinical trial data before it can approve any medicine or treatment for public use as safe and effective.
At Capital Nephrology Clinical Research, our goal is through participation in clinical trials to assist in the development and the collection of important clinical data needed to receive approval of new medicines that will help manage and prolong our patient's quality of life safely. To support the cause of clinical research, Capital Nephrology Clinical Research participates in parmaceutical sponsored clinical trials.
Our patients' voluntary participation in this process is highly appreciated and vitally important in providing the valuable data needed to develop safe and effective medicinal products.
Clinical trials are studies involving drugs or devices managed or sponsored by government agencies (such as National Institutes of Health), educational institutions, not-for-profit organizations or commercial groups that develop, produce and/or evaluate effectiveness of new drug or device therapies.
Clinical trials are strictly conducted under the regulatory oversight of bodies such as Institutional Sponsoring Agency, Review Boards (IRB), Data Safety Monitoring Board (DSMB) and/or Food and Drug Administration (FDA).
There are several processes in place designed to protect the potential participants that include:
Clinical Trial Protocols are a set of sepcific and stringent set of guidelines that must be followed throughout the course of study. These guidelines include:
Participation in a clinical trial is defined by eligibility criteria. The particpants must meet these criteria in order to be eligible to particpate in the trial. Having appropriate eligibility criteria assures that the results answer the questions study was desinged for and also determines who is likely to benefit from the researched drug, procedure or device.
Eligible participants will receive at no cost; study medications, blood pressure checks, study related physical exams, lab testing and electrocardiograms. Compensation for time and travel is available for qualified individuals.
Bard Peripheral Vascular, Inc.
Eli Lilly and Company
Questcor Pharmaceuticals, Inc.
ZS Pharma, Inc.
WorldWide Clinical Trial
Dr. Atray, M.D., FASN